TDOC · Teladoc Health, Inc.
$5.73
+0.06 (+1.06%)
At close · Oct 19
View the 10-Q filed Apr 30, 2026
Return incl. dividend (before tax)
Customer concentration
— key customers 31% of revenue
Key customers — 31% of revenue (the three months ended March 31, 2026)
“Revenue from the five largest Clients accounted for 31% of total Integrated Care segment revenue for each of the three months ended March 31, 2026 and 2025.”
Market Cap
$1.03B
Shares
181.68M
Volume · Oct 19
2.68M
Avg daily vol (3M)
4.26M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$5.73
Open$5.61
Day$5.57–5.75
52W close$4.47–9.72
Avg vol 30d3.5M
Short int30.1M · 16.6% float · 8.9d
Short vol56%
Last earningsOct 28, 2026
DataJan 2020–Oct 2026
Filing10-Q · Jul 30
Up next
Next earnings call
Oct 28, 2026
Scheduled
· in 1 wks
filed Jul 30, 2026
call held Jul 29, 2026
Metrics snapshot
Useful current figures from the complete screener profile.
Revenue (TTM)
$2.49B
Trailing 12 months
Net income (TTM)
−$177.40M
Trailing 12 months
Revenue growth YoY
-4.0%
Year over year
Operating margin
-7.5%
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
24.6%
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+2.9%
Year over year · more shares
Price change (1Y)
-37.1%
Trailing year
Short interest
16.6%
Latest settlement · 8.9 days to cover
Quarterly results
* Q4 derived as the full year minus Q1 to Q3.
Mentioned in fund letters
Equibles Rating
blended score · not investment adviceOverall
Sell
SellHoldBuy
Technical
Neutral
Momentum
Very Weak
Sentiment
Neutral
Fundamentals
Excellent
Quant / Vol
Very High
Market backdrop
VIX 20 · elevated
Equity put/call 0.65
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−12%
below
Price vs 50-day avg
−8%
below
RSI (14)
43
neutral
MACD trend
Positive
52-week position
24%
mid-range
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
−9%
trailing
6-month return
−5%
trailing
YTD return
−18%
this year
Relative strength
−12%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $6 › 200d $6 — 200d above 50d
Institutional flow
Accumulating
38 of 354 funds reported for Sep 30 · net +1.6M sh shares · +3 new
Insider flow
Distributing
Net -$362.7K over 90 days · 100% sells
Short interest
Rising
16.57% of float · ▲ +9.0% MoM · 8.9 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
354 holders — mid 3-yr range
Squeeze score
76
high risk · 0–100
Fundamentals
Revenue growth
+18%
Y/Y
Gross margin
12%
expanding
EPS growth
+81%
Y/Y
Free cash flow
$285.5M
Balance sheet
$5.6M
net cash
Quant / Vol
risk profile
Volatility
61%
annualized · 1-yr
Max drawdown
−53%
past year
ATR
4.4%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Latest guidance
· from the Earnings Call filed Jul 29, 2026
for 2026
BetterHelp segment revenue
$770M – $830M
2026 insurance revenue
$90M – $105M
for the full year
BetterHelp's adjusted EBITDA margin
Non-GAAP
3% – 4.6%
2026
Free cash flow
$130M – $170M
Integrated care revenue growth
0.8% – 2.4%
not stated
Insurance revenue run rate
$90M – $105M
Prior guidance
period ended
· from the 8-K filed Jul 29, 2026
Revenue
· For the third quarter of 2026
$569M – $609M
Adjusted EBITDA
· For the third quarter of 2026
$62M – $74M
Net loss per share
· For the third quarter of 2026
$-0.30 – $-0.20
BetterHelp Adjusted EBITDA margin
· For the third quarter of 2026
0.5% – 2.5%
Integrated Care Revenue growth percentage (year-over-year)
· For the third quarter of 2026
0% – 3%
Integrated Care Adjusted EBITDA margin
· For the third quarter of 2026
15.7% – 17.2%
Guided vs delivered
· last 8 settled
Revenue
2Q 2026
guided $597M – $626M
$606.93M
In line
Net loss per share
2Q 2026
guided $-0.30 – $-0.20
$-0.21
In line
Revenue
1Q 2026
guided $598M – $620M
$613.85M
In line
Revenue
Full Year 2025
guided $2.51B – $2.54B
$2.53B
In line
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders Neutral
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−12%
Bearish
Price vs 50-day avg
−8%
Bearish
RSI (14)
43
Neutral
MACD trend
Positive
Bullish
52-week position
24%
Neutral
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bearish · 2 of 6
Trend (MA cross)
No cross
50d $6 › 200d $6 — 200d above 50d
Institutional flow
Accumulating
38 of 354 funds reported for Sep 30 · net +1.6M sh shares · +3 new
Insider flow
Distributing
Net -$362.7K over 90 days · 100% sells
Short interest
Rising
16.57% of float · ▲ +9.0% MoM · 8.9 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
354 holders — mid 3-yr range
Price context
position in its 52-week range
Range low $4
Now $6 · 24%
Range high $10
vs 200-day avg -12%
vs 50-day avg -8%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Average monthly revenue per U.S. Integrated Care member | $1.31 | the three months ended June 30, 2026 filing | — |
| BetterHelp Adjusted EBITDA non-GAAP | 471K | the three months ended June 30, 2026 filing | — |
| BetterHelp Adjusted EBITDA margin % non-GAAP | 0.2% | the three months ended June 30, 2026 filing | — |
| BetterHelp Paying Users | 0.35M | the three months ended June 30, 2026 filing | — |
| Integrated Care Adjusted EBITDA non-GAAP | 65.24M | the three months ended June 30, 2026 filing | — |
| Integrated Care Adjusted EBITDA margin % non-GAAP | 16.5% | the three months ended June 30, 2026 filing | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Health Information Services — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
TDOC
this stock
Teladoc Health, Inc.
|
$1.03B | -18.1% | +18.4% | — | 16.6% |
|
VEEV
Veeva Systems Inc
|
$50.97B | +41.9% | +28.1% | 51.5 | 3.0% |
|
PMDIY
Pro Medicus Ltd./ADR
|
$12.77B | -26.4% | — | — | 0.0% |
|
BTSG
BrightSpring Health Services, Inc.
|
$12.10B | +63.7% | +28.2% | 37.1 | 6.1% |
|
TEM
Tempus AI, Inc.
|
$11.68B | +9.0% | +83.4% | — | 13.9% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| TDOC | -3.2% | -8.6% | -4.5% | -1.2% | -18.1% |
| SPY | -1.5% | -0.9% | +7.7% | +0.5% | +12.4% |
| vs SPY | -1.7% | -7.7% | -12.2% | -1.7% | -30.5% |
Key facts
CIK
1477449
CUSIP
87918A105
13F (30d)
33 filings
32 filers
Visit website
Investor relations